FILE:BMY/BMY-8K-20050512150150.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
 
 
 
 
Item 8.01. Other Events.
 
On May 11, 2005, Bristol-Myers Squibb Company issued a press release announcing it had completed the sale of its Oncology Therapeutics Network (OTN) distribution business to One Equity Partners LLC. A copy of the press release is attached to this report as Exhibit 99.1.
 
Item 9.01 Financial Statement and Exhibits
 
(c) Exhibits
 
99.1Press release, dated May 11, 2005
    
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

Exhibit 99.1
 
 
 
 
(NEW YORK, May 11, 2005)  Bristol-Myers Squibb Company (NYSE: BMY) today announced that it has completed the sale of its Oncology Therapeutics Network (OTN) distribution business to One Equity Partners LLC.
 
The divestiture of OTN reflects Bristol-Myers Squibb's strategic focus on developing its pipeline and new product opportunities in disease areas of significant unmet medical need where innovative medicines can help people with serious illnesses.
 
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
 


